2.62
-0.04(-1.50%)
Currency In USD
| Previous Close | 2.66 |
| Open | 2.75 |
| Day High | 2.81 |
| Day Low | 2.61 |
| 52-Week High | 19.1 |
| 52-Week Low | 2.32 |
| Volume | 506,228 |
| Average Volume | 900,683 |
| Market Cap | 177.08M |
| PE | -1.97 |
| EPS | -1.33 |
| Moving Average 50 Days | 3.15 |
| Moving Average 200 Days | 9.08 |
| Change | -0.04 |
If you invested $1000 in Perspective Therapeutics, Inc. (CATX) 10 years ago, it would be worth $172.37 as of March 14, 2025 at a share price of $2.62. Whereas If you bought $1000 worth of Perspective Therapeutics, Inc. (CATX) shares 5 years ago, it would be worth $459.65 as of March 14, 2025 at a share price of $2.62.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Perspective Therapeutics to Present at Upcoming March Investor Conferences
GlobeNewswire Inc.
Feb 26, 2025 12:00 PM GMT
SEATTLE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout t
Perspective Therapeutics to Provide Business Highlights and Report Full Year 2024 Financial Results
GlobeNewswire Inc.
Feb 21, 2025 12:00 PM GMT
SEATTLE, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout th
Perspective Therapeutics to Participate in Upcoming February Investor Conferences
GlobeNewswire Inc.
Feb 05, 2025 12:00 PM GMT
SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, tod